Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 17Active not recruiting 8Completed 5Suspended 3Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 2

Interventions

Specimen Handling 39Magnetic Resonance Spectroscopy 26fludarabine 17Cyclophosphamide 16Biopsy 15Paclitaxel 13Gemcitabine 13Carboplatin 13pembrolizumab 11Dexamethasone 11Radiotherapy 9Oxaliplatin 8Drug Therapy 8Cisplatin 8venetoclax 7Radiosurgery 7Nivolumab 7Interviews as Topic 7fludarabine phosphate 6cemiplimab 6Doxorubicin 6Blood Specimen Collection 6Bevacizumab 6durvalumab 5blinatumomab 5Rituximab 5Irinotecan 5Fluorouracil 5Docetaxel 5Capecitabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Azacitidine × 30 days × Clear all
NCT07605949 2026-05-27

RAVEN

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
88 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07581002 2026-05-12

REVIVAL

AbbVie

Phase 2/3 Not yet recruiting
660 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡